Preference and Willingness to Pay for the Regular COVID-19 Booster Shot in the Vietnamese Population: Theory-Driven Discrete Choice Experiment

Background The COVID-19 booster vaccination rate has declined despite the wide availability of vaccines. As COVID-19 is becoming endemic and charges for regular booster vaccination are being introduced, measuring public acceptance and the willingness to pay for regular COVID-19 boosters is ever more crucial. Objective This study aims to (1) investigate public acceptance for regular COVID-19 boosters, (2) assess the willingness to pay for a COVID-19 booster shot, and (3) identify factors associated with vaccine hesitancy. Our results will provide crucial insights into and implications for policy response as well as the development of a feasible and effective vaccination campaign during Vietnam’s waning vaccine immunity period. Methods A cross-sectional study was conducted among 871 Vietnamese online participants from April to August 2022. An online questionnaire based on the discrete choice experiment (DCE) design was developed, distributed using the snowball sampling method, and subsequently conjointly analyzed on the Qualtrics platform. A history of COVID-19 infection and vaccination, health status, willingness to vaccinate, willingness to pay, and other factors were examined. Results Among the participants, 761 (87.4%) had received or were waiting for a COVID-19 booster shot. However, the willingness to pay was low at US $8.02, and most participants indicated an unwillingness to pay (n=225, 25.8%) or a willingness to pay for only half of the vaccine costs (n=222, 25.4%). Although information insufficiency and a wariness toward vaccines were factors most associated with the unwillingness to pay, long-term side effects, immunity duration, and mortality rate were the attributes the participants were most concerned with during the vaccine decision-making period. Participants who had children less than 18 years old in their homes infected with COVID-19 had a lower willingness to pay (odds ratio [OR] 0.54, 95% CI 0.39-0.74). Respondents who had children under 12 years old in their family who received at least 1 vaccine dose had a higher willingness to pay (OR 2.03, 95% CI 1.12-3.66). The burden of medical expenses (OR 0.33, 95% CI 0.25-0.45) and fear of the vaccine (OR 0.93, 95% CI 0.86-1.00) were negative factors associated with the level of willingness to pay. Conclusions A significant inconsistency between high acceptance and a low willingness to pay underscores the role of vaccine information and public trust. In addition to raising awareness about the most concerning characteristics of the COVID-19 booster, social media and social listening should be used in collaboration with health professionals to establish a 2-way information exchange. Work incentives and suitable mandates should continue to encourage workforce participation. Most importantly, all interventions should be conducted with informational transparency to strengthen trust between the public and authorities.

[1]  N. Youssef,et al.  Acceptance of COVID-19 Vaccine Booster Doses Using the Health Belief Model: A Cross-Sectional Study in Low-Middle- and High-Income Countries of the East Mediterranean Region , 2022, International journal of environmental research and public health.

[2]  Leesa Lin,et al.  Mapping global acceptance and uptake of COVID-19 vaccination: A systematic review and meta-analysis , 2022, Communications Medicine.

[3]  Deepti Hooda,et al.  Assessing COVID-19 Booster Hesitancy and Its Correlates: An Early Evidence from India , 2022, Vaccines.

[4]  N. Kigozi,et al.  Factors Associated with Limited Vaccine Literacy: Lessons Learnt from COVID-19 , 2022, Vaccines.

[5]  N. Basta,et al.  What drives willingness to receive a new vaccine that prevents an emerging infectious disease? A discrete choice experiment among university students in Uganda , 2022, PloS one.

[6]  Caijun Sun,et al.  Acceptance of COVID‐19 booster vaccination based on the protection motivation theory: A cross‐sectional study in China , 2022, Journal of medical virology.

[7]  Haitao Song,et al.  Impact of low vaccine coverage on the resurgence of COVID-19 in Central and Eastern Europe , 2022, One Health.

[8]  B. Martínez-Jarreta,et al.  Citizen Stance towards Mandatory COVID-19 Vaccination and Vaccine Booster Doses: A Study in Colombia, El Salvador and Spain , 2022, Vaccines.

[9]  Kawthar Mohamed,et al.  Longevity of immunity following COVID-19 vaccination: a comprehensive review of the currently approved vaccines , 2022, Human vaccines & immunotherapeutics.

[10]  Nguyen Ngọc Anh Tien,et al.  Protecting right to health in developing countries during the pandemic of COVID-19 , 2022, International journal of health sciences.

[11]  S. Ayers,et al.  Video-based messages to reduce COVID-19 vaccine hesitancy and nudge vaccination intentions , 2022, PloS one.

[12]  S. Gharbia,et al.  Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant , 2022, The New England journal of medicine.

[13]  J. Al-Tawfiq,et al.  COVID-19 in Southeast Asia: current status and perspectives , 2022, Bioengineered.

[14]  F. Paolucci,et al.  An analysis of the COVID-19 vaccination campaigns in France, Israel, Italy and Spain and their impact on health and economic outcomes , 2021, Health Policy and Technology.

[15]  Jiahao Wang,et al.  Public Perceptions and Acceptance of COVID-19 Booster Vaccination in China: A Cross-Sectional Study , 2021, Vaccines.

[16]  K. Batra,et al.  Assessing Acceptability of COVID-19 Vaccine Booster Dose among Adult Americans: A Cross-Sectional Study , 2021, Vaccines.

[17]  D. Beiser,et al.  Effectiveness of mRNA Covid-19 Vaccine among U.S. Health Care Personnel , 2021, The New England journal of medicine.

[18]  P. Dormitzer,et al.  Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months , 2021, The New England journal of medicine.

[19]  J. Nelson,et al.  Surveillance for Adverse Events After COVID-19 mRNA Vaccination. , 2021, JAMA.

[20]  L. Tserel,et al.  Dynamics of antibody response to BNT162b2 vaccine after six months: a longitudinal prospective study , 2021, The Lancet Regional Health - Europe.

[21]  L. D. Nguyen,et al.  Acceptance and willingness to pay for COVID‐19 vaccines among pregnant women in Vietnam , 2021, Tropical medicine & international health : TM & IH.

[22]  M. Davenport,et al.  Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection , 2021, Nature Medicine.

[23]  G. Huynh,et al.  Knowledge About COVID-19, Beliefs and Vaccination Acceptance Against COVID-19 Among High-Risk People in Ho Chi Minh City, Vietnam , 2021, Infection and drug resistance.

[24]  George M. Slavich,et al.  The Impact of Stress and Coping Strategies on Life Satisfaction in a National Sample of Adolescents: A Structural Equation Modelling Approach. , 2021, Stress and health : journal of the International Society for the Investigation of Stress.

[25]  Hannah Ritchie,et al.  A global database of COVID-19 vaccinations , 2021, Nature Human Behaviour.

[26]  J. Li,et al.  The role of communication transparency and organizational trust in publics' perceptions, attitudes and social distancing behaviour: A case study of the COVID‐19 outbreak , 2021, Journal of Contingencies and Crisis Management.

[27]  S. Lees,et al.  Trust and transparency in times of crisis: Results from an online survey during the first wave (April 2020) of the COVID-19 epidemic in the UK , 2020, medRxiv.

[28]  T. Arora,et al.  Health behaviour changes during COVID-19 and the potential consequences: A mini-review , 2020, Journal of health psychology.

[29]  Ong Eng Koon The Impact of Sociocultural Influences on the COVID-19 Measures—Reflections From Singapore , 2020, Journal of Pain and Symptom Management.

[30]  J. Castaldelli-Maia,et al.  The outbreak of COVID-19 coronavirus and its impact on global mental health , 2020, The International journal of social psychiatry.

[31]  M. Jit,et al.  Quantifying the public's view on social value judgments in vaccine decision-making: A discrete choice experiment. , 2019, Social science & medicine.

[32]  P. Beutels,et al.  Drivers of vaccine decision-making in South Africa: A discrete choice experiment. , 2019, Vaccine.

[33]  M. Izaute,et al.  How can the health belief model and self-determination theory predict both influenza vaccination and vaccination intention ? A longitudinal study among university students , 2018, Psychology & health.

[34]  T. Kan,et al.  Factors influencing seasonal influenza vaccination behaviour among elderly people: a systematic review , 2018, Public Health.

[35]  G. Bonsel,et al.  The impact of vaccination and patient characteristics on influenza vaccination uptake of elderly people: A discrete choice experiment. , 2018, Vaccine.

[36]  J. Müller-Nordhorn,et al.  Quantifying population preferences around vaccination against severe but rare diseases: A conjoint analysis among French university students, 2016. , 2017, Vaccine.

[37]  G. Haugan,et al.  The Association Between School Stress, Life Satisfaction and Depressive Symptoms in Adolescents: Life Satisfaction as a Potential Mediator , 2016 .

[38]  E. Steyerberg,et al.  Acceptance of Vaccinations in Pandemic Outbreaks: A Discrete Choice Experiment , 2014, PloS one.

[39]  Heidi J Larson,et al.  Public health response to influenza A(H1N1) as an opportunity to build public trust. , 2010, JAMA.

[40]  Shannon M. Suldo,et al.  Does life satisfaction moderate the effects of stressful life events on psychopathological behavior during adolescence , 2004 .

[41]  Shannon M. Suldo,et al.  Life satisfaction in children and youth: Empirical foundations and implications for school psychologists , 2004 .

[42]  I. Ajzen,et al.  Understanding Attitudes and Predicting Social Behavior , 1980 .